Risk factors associated with positive quantiFERON-TB gold in-tube and tuberculin skin tests results in Zambia and South Africa

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Shanaube, Kwame ^a   Hargreaves, James ^b   Fielding, Katherine ^b   Schaap, Ab ^a,b   Lawrence, Katherine Anne ^c   Hensen, Bernadette ^b   Sismanidis, Charalambos ^d   Menezes, Angela ^c   Beyers, Nulda ^c   Ayles, Helen ^a,b   Godfrey Faussett, Peter ^b  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTACT EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GAMMA INTERFERON RELEASE ASSAY; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; QUESTIONNAIRE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM SMEAR; TUBERCULIN TEST; TUBERCULOSIS; ZAMBIA; DISEASE TRANSMISSION; HOUSING; INFORMATION PROCESSING; LATENT TUBERCULOSIS; METABOLISM; MIDDLE AGED; PATHOGENICITY; SECRETION;

ADOLESCENT; ADULT; AGED; DATA COLLECTION; FEMALE; HIV INFECTIONS; HOUSING; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; SOUTH AFRICA; TUBERCULIN TEST; YOUNG ADULT; ZAMBIA;

EID: 79953710546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018206     Document Type: Article

References (46)

1. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC, (2005) Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally. JAMA 293: 2767-2775.
2. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, et al. (1992) An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency Virus. New England Journal of Medicine 326: 231-235.
3. Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, et al. (1993) A prospective study of the risk of tuberculosis among HIV-infected patients. Aids 7: 1345-1349.
4. Centers for Disease Control and Prevention (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 49 (6).
5. World Health Organization, Department of HIV/AIDS, Stop TB Department (2011) Guidelines for intensified tuberculosis case finding and isoniazid preventive therapy for people living with HIV in resource constrained settings.
6. Fine PE, Bruce J, Ponnighaus JM, Nkhosa P, Harawa A, et al. (1999) Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis 3: 962-975.
7. Pai M, Zwerling A, Menzies D, (2008) Systematic Review: T-Cell based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update. Ann Intern Med 149: 177-184.
8. Pai M, Kalantri S, Dheda K, (2006) New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 6: 413-422.
9. Raby E, Moyo M, Devendra A, Banda J, De Haas P, et al. (2008) The effects of HIV on the sensitivity of a whole blood IFN-γ release assay in Zambian adults with active tuberculosis. PLoS ONE 3: e2489.
10. Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, et al. (2002) Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. Aids 16: 2285-2293.
11. Mack U, Migliori GB, Sester M, Reider HL, Ehlers S, et al. (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33: 956-973.
12. Canadian Tuberculosis Committee (2007) Interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 33: 1-18.
13. Centers for Disease Control and Prevention (2005) Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 54(No. RR-17): 1-141.
14. Dheda K, Smit RVZ, Badri M, Pai M, (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Current Opinion in Pulmonary Medicine 15: 188-200.
15. Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, et al. (2006) Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 28: 24-30.
16. Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, et al. (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: A systematic review and meta-analysis. J Acquir Immune Defic Syndr 56: 230-238.
17. Thomas TA, Mondal D, Noor Z, Liu L, Alam M, et al. (2010) Malnutrition and Helminth Infection Affect Performance of an Interferon {gamma}-Release Assay. Pediatrics 126: e1522-1529.
18. Lalvani A, Pareek M, (2010) Interferon gamma release assays: principles and practice. Enfermedades infecciosas y Microbiologia Clinica 28: 245-252.
19. Hesseling AC, Mandalakas AM, Kirchner HL, Chegou NN, Marais BJ, et al. (2009) Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 64: 840-846.
20. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, et al. (2003) Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361: 1168-1173.
21. Hill PC, Brookes RH, Fox A, Fielding K, Jeffries DJ, et al. (2004) Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 38: 966-973.
22. Shanaube K, Sismanidis C, Ayles H, Beyers N, Schaap A, et al. (2009) Annual Risk of Tuberculous Infection Using Different Methods in Communities with a High Prevalence of TB and HIV in Zambia and South Africa. PLoS ONE 4: e7749.
23. Rieder HL, Chadha VK, Nagelkerke NJD, Van Leth F, VanderWerf MJ, (2011) Guidelines for conducting tuberculin skin test surveys in high-prevalence countries. Int J Tuber Lung Dis 15: S1-S25.
24. Ayles H, Sismanidis C, Beyers N, Hayes R, Godfrey-Faussett P, (2008) ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2×2 factorial community randomized trial. Trials 9: 63.
25. Sismanidis C, Moulton LH, Ayles H, Fielding K, Schaap A, et al. (2008) Restricted randomization of ZAMSTAR: a 2×2 factorial cluster randomized trial. Clinical Trials 5: 316-327.
26. World Health Organization (2009) Global tuberculosis control: epidemiology, strategy, financing report. WHO/HTM/TB/2009.411.
27. Central Statistical Office (CSO), Ministry of Health (MOH), Tropical Diseases Research Centre (TDRC), University of Zambia, and Macro International Inc (2009) Zambia Demographic and Health Survey 2007. Calverton, Maryland, USA CSO and Macro International Inc.
28. Department of Health Republic of South Africa (2010) Guidelines for tuberculosis preventive therapy among HIV infected individuals in South Africa.
29. (2007) QuantiFERON-TB Gold (In-Tube Method) Package insert. Doc. No. 142 05990301B.
30. Duncan LE, Elliott AM, Hayes RJ, Hira SK, Tembo G, et al. (1995) Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study. Transactions of the Royal Society of Tropical Medicine and Hygiene 89: 37-40.
31. Mutsvangwa J, Millington KA, Chaka K, Mavhudzi T, Cheung Y-B, et al. (2010) Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden. Thorax 65: 315-320.
32. Zellweger JP, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P, (2005) Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 9: 1242-1247.
33. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri SP, et al. (2005) Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood, interferon-γ assay with tuberculin skin testing. JAMA 293: 2746-2755.
34. del Corral H, Paris SC, Marin ND, Marin DM, Lopez L, et al. (2009) IFN-gamma responses to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS ONE 4: e8257.
35. Schaaf HS, Michaelis IA, Richardson M, Booysen CN, Gie RP, et al. (2003) Adult-to-child transmission of tuberculosis: household or community contact? The International Journal of Tuberculosis and Lung Disease 7: 426-431(426).
36. Verver S, Warren RM, Munch Z, Richardson M, van der Spuy GD, et al. (2004) Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet 363: 212-214.
37. Classen CN, Warren R, Richardson M, Hauman JH, Gie RP, et al. (1999) Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area. Thorax 54: 136-140.
38. Boccia D, Hargreaves J, Ayles H, Fielding K, Simwinga M, et al. (2009) Tuberculosis infection in Zambia: the association with relative wealth. Am J Trop Med Hyg 80: 1004-1011.
39. Lewinsohn DA, Zalwango S, Stein CM, Mayanja-Kizza H, Okwera A, et al. (2008) Whole Blood Interferon-Gamma Responses to Mycobacterium tuberculosis Antigens in Young Household Contacts of Persons with Tuberculosis in Uganda. PLoS ONE 3: e3407.
40. Mahomed H, Hughes EJ, Hawkridge T, Minnies D, Simon E, et al. (2006) Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis 10: 310-316.
41. Davidow AL, Affouf M, (2008) Making sense of agreement among interferon-gamma release assays and tuberculosis skin testing. Int J Tuber Lung Dis 12: 152-159.
42. Balcells ME, Pérez CM, Chanqueo L, Lasso M, Villanueva M, et al. (2008) A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. International journal of infectious diseases 12: 645-652.
43. Pai M, Dendukuri N, Wang L, Joshi R, Kalantri SP, et al. (August 2008) Improving the estimation of tuberculosis infection prevalence using T-cell-based assay and mixture models. The International Journal of Tuberculosis and Lung Disease 12: 895-902(898).
44. Adetifa IM, Lugos MD, Hammond A, Jeffries D, Donkor S, et al. (2007) Comparison of Two Interferon Gamma Release Assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis 7: 122.
45. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, et al. (2005) Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon-gamma Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country. JAMA 293: 2756-2761.
46. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, et al. (2006) Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 27: 442-448.